M&G Plc (MNG)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 312.30 |
|---|---|
| 52-week range | 256.70 – 367.10 |
| Return, 1 month / 3 months | −5.6% / −12.6% |
| Return, 1 year / 3 years | +19.5% / +62.0% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 20.5% |
| Worst drawdown (1 year) | -16.5% |
| Average daily value traded | 1,979.61M GBX |
| Dividend yield | 6.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
M&G Plc is a savings and investment business based in the United Kingdom. It manages investments on behalf of individual savers and institutional clients, offering products such as savings accounts, individual savings accounts, pensions and investment funds. Its asset management arm invests in assets including bonds, equities and property. The company serves retail customers and institutions, and it also provides life and pension products through its insurance operations.
The shares are listed on the London Exchange in UK under the code MNG, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
M&G Plc (MNG) trades on the London Exchange in UK. It last closed at GBX 312.30 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 602 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.5% and over the last three months it fell 12.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.2% | ||
| From 52-week high | -14.3% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.6% | ||
| 6-month return | 6.6% | ||
| 12-month return, skipping the last month | 26.5% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.5% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 1,979.61M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | −5.6% |
| 3 months | −12.6% |
| 6 months | +6.6% |
| 1 year | +19.5% |
| 3 years | +62.0% |
| 5 years | +58.1% |
Signals
| 50-day / 200-day average | 331.61 / 319.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.87 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | GBP 0.0680 |
| 19 Mar 2026 | GBP 0.1380 |
| 11 Sep 2025 | GBP 0.0670 |
| 27 Mar 2025 | GBP 0.1350 |
| 12 Sep 2024 | GBP 0.0660 |
| 28 Mar 2024 | GBP 0.1320 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.